Independent Drug Education and Outreach Act of 2008

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

Client expense: $3,250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)

S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT OF 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness

Client expense: $6,170,000 · Firm income: Not reported

H.R. 6752 / S. 3396: Independent Drug Education Act

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

The Genetic Information Nondiscrimination Act of 2007 (H.R. 493), introduced by Rep. Louise Slaughter (D-NY) amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to expand the prohibition against discrimination by group health plans and health insurance issuers in the group and individual markets on the basis of genetic information or services to prohibit: (1) enrollment and premium discrimination based on information about a request for or receipt of genetic services; and (2) requiring genetic testing. The Physician Payments Sunshine Act (S. 2029) introduced by Senator Herb Kohl This Senate bill and its House counterpart HR 5605 would require drug and medical device makers to disclose gifts and payments to doctors, which would be listed online in a publicly accessible database. Marshfield Clinic has internal policies prohibiting acceptance of gifts of any kind that might be intended to affect the judgment and discretion of it physicians, providers and staff. S 3396, the Independent Drug Education and Outreach Act of 2008, introduced by Senator Herb Kohl, a bill that provides grants or contracts for prescription drug education and outreach for healthcare providers and their patients. On November. 12, Sen. Max Baucus (D-MT), chairman of the Senate Finance Committee, released a white paper on health reform, entitled Call to Action which proposes reforms of the health care system, including major expansions of public health care programs, Medicare reforms, tax breaks for small businesses, requiring larger employers to provide health insurance coverage to their workers or pay into a coverage fund, and requiring all Americans to have health insurance. Marshfield Clinic has specific concerns regarding the Expansion of public programs: Temporarily allowing people age 55-64 to buy in to Medicare until an insurance exchange is up and running. Marshfield Clinic supports Proposals to reform payment to focus on value-based purchasing and also to promote primary care and coordinated delivery. The White Paper calls on the Centers for Medicare and Medicaid Services (CMS) to develop a framework to reform and expand the Physician Group Practice Demonstration project in 2010, for its fifth year. Using the results of the project, Baucus also proposes that Medicare develop a new pilot program to test cost and quality opportunities of value-based payment to Accountable Care Organization (ACOs).

-S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-NO BILL NUMBER - Review revisions to FDA draft drug safety title, specific interest in the recognition of standards -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-NO BILL NUMBER - Review revisions of FDA draft drug safety title, specific interest in the recognition of standards -S. 3385: FDA Food Safety and Modernization Act, Regarding all provisions -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

H.R. 1424, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (as included in the Emergency Economic Stabilization Act of 2008), provisions on mental health parity and physician-owned hospitals H.R. 6983, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, all provisions S. 558 Mental Health Parity Act of 2007, all provisions S. 3335, Jobs, Energy, Families, and Disaster Relief Act of 2008, provisions on mental health parity H.R. 6049, Energy and Tax Extenders Act of 2008, provisions on mental health parity H.R. 6357, PRO(TECH)T Act of 2008, all provisions H.R. 6898, Health-e Information Technology Act of 2008, all provisions S. 1693, Wired for Health Care Quality Act, provisions relating to data collection, quality, and performance reporting H.R. 6179, Promoting Health Information Technology Act of 2008, all provisions S. 3300, Rural Hospital Assistance Act of 2008, provisions on physician-owned hospitals and self-referral S. 334, Healthy Americans Act, all provisions H.R. 6569, Public Health Emergency Response Act of 2008, all provisions H.R. 1841, AmeriCare Health Care Act of 2007, all provisions H.R. 2357, MediKids Health Insurance Act of 2007, all provisions H.R. 5873, Family Leave Insurance Act of 2008, all provisions H.R. 5639, Physical Activity Guidelines for Americans Act of 2008, all provisions H.R. 3257, Fitness Integrated with Teaching Kids Act, all provisions S. 3575, Labeling Education and Nutrition Act of 2008 (LEAN Act of 2008), all provisions H.R. 2833, Preexisting Condition Exclusion Patient Protection Act of 2007, all provisions H.R. 2842, Children's Health Protection Act of 2007, all provisions H.R. 6845, Fair Copyright in Research Works Act, all provisions H.R. 3544, Catalyst to Better Diabetes Care Act of 2007, all provisions H.R. 1532, Comprehensive Tuberculosis Elimination Act of 2007, all provisions H.R. 2994, National Pain Care Policy Act of 2007, all provisions H.R. 1283, Arthritis Prevention, Control, and Cure Act of 2007, all provisions S. 2731, to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes, all provisions S. 3040 and H.R. 6100, Kid-Safe Chemicals Act of 2008, all provisions H.R. 2464, to amend the Public Health Service Act to provide a means for continued improvement in emergency medical services for children, all provisions H.R. 7192, Preserving Patient Access to Primary Care Act, all provisions H.R. 758, Breast Cancer Patient Protection Act of 2008, all provisions S. 3354, Volunteer Healthcare Program Act of 2008, all provisions S. 3408, Comparative Effectiveness Research Act of 2008, all provisions H.R. 6752 and S. 3396, Independent Drug Education and Outreach Act of 2008, all provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, all provisions H.R. 5620, Fresh Produce Safety Act, all provisions H.R. 1038 and S. 623, to amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes, all provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, all provisions S. 1505, Affordable Biologics for Consumers Act, all provisions H.R. 6498 and S. 976, Genomics and Personalized Medicine Act of 2008, all provisions H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, all provisions Health Disparities Inclusion of Minorities in Clinical Trials Health Savings Accounts Medical devices - standardization of expiration dates Disability Nondiscrimination (Americans with Disabilities Act/hearing interpreters) The Uninsured, AMA's Plan Childhood Obesity Social Security Administration Disability Claims Processing Blood and Blood Components Safety Pregnancy and Lactation Prescription Drug and Biological Products Labeling Children's Health Insurance Program Directive Post-marketing Surveillance of Prescription Drugs DEA - E-Prescribing Constraints E-Prescribing Incentive Program Provider Conscience Clause Home Stockpiling of Antivirals National Ambient Air Quality for Lead

H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues H.R. 758, Price Disclosure Regarding Treatment of Breast Cancer: transparency H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007: Medicaid rebate H.R. 2184, Enhanced Health Care Value for All Act of 2007: comparative effectiveness H.R. 3162, Children's Health and Medicare Protection Act of 2007: Medicaid rebate H.R. 4854, False Claims Act Correction Act of 2007: liability issues H.R. 5605, Physician Payments Sunshine Act of 2008: transparency issues H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6684, Medicare Prescription Drug Cost Equalization Act: Part D issues H.R. 6752, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3, Medicare Prescription Drug Price Negotiation Act of 2007: Part D issues S. 558, Mental Health Parity Act of 2007: health insurance issues S. 2029, Physician Payments Sunshine Act of 2007: transparency issues S. 2041, False Claims Act Correction Act of 2007: liability issues S.3101, Medicare Improvements for Patients and Providers Act of 2008: comparative effectiveness, federal upper limit for Medicaid pharmacy reimbursement, electronic prescribing, Part D data disclosure, and other issues S. 3118, Preserving Access to Medicare Act of 2008: electronic prescribing, Part D data disclosure, and other issues S. 3396, The Independent Drug Education and Outreach Act of 2008: direct to physician marketing S. 3408, Comparative Effectiveness Research Act of 2008: comparative effectiveness

S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL

Client expense: $490,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S877: CONTROLLING THE ABUSE OF PRESCRIPTIONS ACT OF 2007; DRUG IMPORTATION ASPECTS HR4911: HUMAN GROWTH HORMONE RESTRICTION ACT 2007; ALL PROVISIONS OF BILL HR1038: ACCESS TO LIFE SAVING MEDICINE ACT; FOLLOW-ON BIOLOGICS PROVISIONS HR1956: PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINES ACT OF 2007; FOLLOW ON BIOLOGICS HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL PROVISIONS OF BILL S1505: AFFORDABLE BIOLOGICS FOR CONSUMERS ACT; FOLLOW ON BIOLOGICS S1695: BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; FOLLOW ON BIOLOGICS S623: ACCESS TO LIFE-SAVING MEDICINE ACT; FOLLOW ON BIOLOGICS HR5839: SAFEGUARDING AMERICA'S PHARMACEUTICALS ACT OF 2008; ALL PROVISIONS OF BILL HR6752/S3396: INDEPENDENT DRUG EDUCATION AND OUTREACH ACT OF 2008; ALL PROVISIONS OF BILL

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Genetic Information Nondiscrimination Act of 2007 (H.R. 493), introduced by Rep. Louise Slaughter (D-NY) amends the Employee Retirement Income Security Act of 1974 (ERISA) and the Public Health Service Act to expand the prohibition against discrimination by group health plans and health insurance issuers in the group and individual markets on the basis of genetic information or services to prohibit: (1) enrollment and premium discrimination based on information about a request for or receipt of genetic services; and (2) requiring genetic testing. The Physician Payments Sunshine Act (S. 2029) introduced by Senator Herb Kohl This Senate bill and its House counterpart HR 5605 would require drug and medical device makers to disclose gifts and payments to doctors, which would be listed online in a publicly accessible database. Marshfield Clinic has internal policies prohibiting acceptance of gifts of any kind that might be intended to affect the judgment and discretion of it physicians, providers and staff. S 3396, the Independent Drug Education and Outreach Act of 2008, introduced by Senator Herb Kohl, a bill that provides grants or contracts for prescription drug education and outreach for healthcare providers and their patients.

Client expense: $110,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), SENATE

-S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-NO BILL NUMBER - Review revisions of FDA draft drug safety title, specific interest in the recognition of standards -S. 3385: FDA Food Safety and Modernization Act, Regarding all provisions -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-NO BILL NUMBER - Review revisions to FDA draft drug safety title, specific interest in the recognition of standards -S. 3396: Independent Drug Education Outreach Act of 2008, Regarding all provisions -S. 3408: Comparative Effectiveness Research Act of 2008, Regarding all provisions -Review draft legislation on medication errors

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported

Issues relating to advancing public health through public standards and related programs that help ensure the quality, safety and benefit of medicines and foods. Revised FDA draft drug safety title; S 3385: FDA Food Safety Modernization Act, all provisions; S 3396: Independent Drug Education Outreach Act of 2008, all provisions; S 3408, Comparative Effectiveness Research Act of 2008, all provisions; Draft legislation on medication errors; FDA draft guidance for industry: Voluntary Third Party Certification.

Client expense: Not reported · Firm income: Not reported